1	Hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	0-6	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	de	de	SPS00	C0332285	atributo	7-9	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	38	38		-	-	10-12	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	años	año	NCMP000	C0439234	calificador	13-17	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
5	que	que	PR0CN000	-	-	18-21	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
6	consulta	consultar	VMM02S0	C1704447_1	calificador_1	22-30	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
7	por	por	SPS00	C1704447_2	calificador_2	31-34	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
8	disnea	disnea	NCFS000	C0013404#C0553668	hallazgo	35-41	232_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
9	y	y	CC	C1706368	calificador	42-43	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
10	hemoptisis	hemoptisis	NCFN000	C0019079	trastorno	44-54	232_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
11	.	.	Fp	-	-	54-55	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	56-58	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	los	el	DA0MP0	-	-	59-62	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	análisis	análisis	NCMN000	C0702196_1	situación_1	63-71	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	de	de	SPS00	C0702196_2	situación_2	72-74	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	sangre	sangre	NCFS000	C0702196_3	situación_3	75-81	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
6	tiene	tener	VMIP3S0	-	-	82-87	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
7	creatinina	creatinina	NC00SC0	C0010294	sustancia	88-98	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
8	7	7	Z	-	-	99-100	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
9	mg	mg	NCMN000	-	-	101-103	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
10	/	/	Fh	-	-	103-104	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
11	dl	decilitro	NCMN000	C0439241	calificador	104-106	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
12	,	,	Fc	-	-	106-107	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
13	urea	urea	NCFS000	C0041942	sustancia	108-112	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
14	250	250	Z	-	-	113-116	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
15	mg	mg	NCMN000	-	-	117-119	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
16	/	/	Fh	-	-	119-120	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
17	dl	decilitro	NCMN000	C0439241	calificador	120-122	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
18	y	y	CC	C1706368	calificador	123-124	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
19	anti-MBG	anti-mbg	NCMS000	-	-	125-133	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
20	(	(	Fpa	-	-	134-135	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
21	anticuerpos	anticuerpo	NCMP000	C0003241	sustancia	135-146	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
22	anti	anti	AQ0CN0	-	-	147-151	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
23	membrana	membrana	NCFS000	C0004799#C0085872_1	estructura_corporal_1	152-160	232_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-	-	-	-
24	basal	basal	NC00SC0	C0004799#C0085872_2	estructura_corporal_2	161-166	232_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-	23	106	MultiE
25	glomerular	glomerular	AQ0CS0	-	-	167-177	232_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-	23	106	MultiE
26	)	)	Fpt	-	-	177-178	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
27	positivos	positivo	AQ0MP0	C1446409	calificador	179-188	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
28	a	a	SPS00	-	-	189-190	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
29	título	título	NCMS000	C0475208	calificador	191-197	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
30	alto	alto	AQ0MS0	C0205250	calificador	198-202	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
31	.	.	Fp	-	-	202-203	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	Se	se	P00CN000	-	-	204-206	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	realiza	realizar	VMIP3S0	-	-	207-214	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	biopsia	biopsia	NCFS000	C0194073_1	procedimiento_1	215-222	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	renal	renal	AQ0CS0	C0194073_2	procedimiento_2	223-228	232_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-	-	-	-
5	que	que	PR0CN000	-	-	229-232	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
6	muestra	mostrar	VMIP3S0	-	-	233-240	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
7	semilunas	semiluna	NCFP000	-	-	241-250	232_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	-	-	-
8	en	en	SPS00	C1720294#C0332285	calificador#atributo	251-253	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
9	el	el	DA0MS0	-	-	254-256	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
10	75	75	Z	-	-	257-259	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
11	%	%	Ft	-	-	259-260	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
12	de	de	SPS00	C0332285	atributo	261-263	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
13	los	el	DA0MP0	-	-	264-267	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
14	glomerulos	glomerulos	NCMP000	-	-	268-278	232_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-	7	1658	LOC
15	y	y	CC	C1706368	calificador	279-280	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
16	en	en	SPS00	C1720294#C0332285	calificador#atributo	281-283	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
17	la	el	DA0FS0	-	-	284-286	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
18	inmunofluorescencia	inmunofluorescencia	NCFS000	C0079603	procedimiento	287-306	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
19	aparece	aparecer	VMIP3S0	-	-	307-314	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
20	un	un		C0205447_1	calificador_1	315-317	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
21	patrón	patrón	NCMS000	C0449774	atributo	318-324	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
22	depósito	depósito	NCMS000	C0442627#C0333562	medio_ambiente#anomalía_morfológica	325-333	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
23	lineal	lineal	AQ0CS0	C0205132	calificador	334-340	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
24	de	de	SPS00	C0332285	atributo	341-343	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
25	Ig	ig	NC00YL0	-	-	344-346	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
26	.	.	Fp	-	-	346-347	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

